By Kenneth J. Craddock, Shirley Tam, Chang-Qi Zhu, Ming-Sound Tsao (auth.), Ulrich Pfeffer (eds.)
The blend of molecular biology, engineering and bioinformatics has revolutionized our knowing of melanoma revealing a decent correlation of the molecular features of the first tumor when it comes to gene expression, structural changes of the genome, epigenetics and mutations with its propensity to metastasize and to answer treatment. it isn't only one or a number of genes, it's the advanced alteration of the genome that determines melanoma improvement and development. destiny administration of melanoma sufferers will as a result depend on thorough molecular analyses of every unmarried case.
Through this ebook, scholars, researchers and oncologists will receive a complete photograph of what the 1st ten years of melanoma genomics have printed. specialists within the box describe, melanoma by way of melanoma, the development made and its implications for analysis, diagnosis and remedy of melanoma. The deep effect at the clinics and the problem for destiny translational learn turn into glaring.
Read or Download Cancer Genomics: Molecular Classification, Prognosis and Response Prediction PDF
Similar cancer books
Brain - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
It is a 3-in-1 reference booklet. It provides a whole scientific dictionary masking thousands of phrases and expressions in relation to mind. It additionally provides huge lists of bibliographic citations. ultimately, it offers details to clients on how one can replace their wisdom utilizing numerous net assets. The e-book is designed for physicians, scientific scholars getting ready for Board examinations, scientific researchers, and sufferers who are looking to familiarize yourself with examine devoted to mind.
Antifolate Drugs in Cancer Therapy
In Antifolate medicinal drugs in melanoma treatment, Ann Jackman and a panel of very hot researchers comprehensively overview the present prestige of novel antifolates, an enormous type of anticancer medications. the celebrated individuals speak about the preclinical and medical pharmacology of methotrexate, different dihydrofolate reductase inhibitors, 5-fluorouracil, and the recent new release of antifolates-the thymidylate synthase and glycinamide ribonucleotide formyltransferase inhibitors.
- Ah shit j'ai pogné le cancer (Tome 2)
- Cancer Explained: The Essential Guide to Diagnosis and Management
- Childhood Brain & Spinal Cord Tumors A Guide for Families, Friends & Caregivers
- Telling It Like It Is: 23 Breast Cancer Journeys
- Cancer and Zebrafish: Mechanisms, Techniques, and Models
Extra resources for Cancer Genomics: Molecular Classification, Prognosis and Response Prediction
Example text
Nat Rev Cancer 7(10):778–790 ˜ res E, Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, Chansky K, 7. ValliAR Shaikh Z, Goldstraw P (2009) The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 4(9):1049–1059 8. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.
J Clin Oncol 23(25):5900–5909. 857 42. Kosaka T, Yatabe Y, Onozato R, Kuwano H, Mitsudomi T (2009) Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol 4(1):22–29. 0b013e3181914111 43. Mascaux C, Iannino N, Martin B, Paesmans M, Berghmans T, Dusart M, Haller A, Lothaire P, Meert AP, Noel S, Lafitte JJ, Sculier JP (2005) The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis.
Guo NL, Wan YW, Bose S, Denvir J, Kashon ML, Andrew ME (2011) A novel network model identified a 13-gene lung cancer prognostic signature. Int J Comput Biol Drug Des 4(1):19–39. 038655 [pii] 137.